Low-Inflammatory RNABL Delivery Enables Organ-Specific Therapeutic RNA Applications
2:30 pm - Monday 20th July 2026
- Introducing non-inflammatory, biodegradable RNABL dendritic molecules for nucleic acid complexation and in vivo delivery
- Showcasing Organ tunability and safety profile of RNABL formulations
- Demonstrating successful therapeutic applications in animal models